The size of the European Pharmaceutical Membrane Filtration Market was worth USD 1.89 billion in 2020 and is likely to grow at a CAGR of 10.1% to reach USD 3.05 billion by 2025.
Rapid growth in generics production, quick acceptance of nanofiltration technology, and a regular surge in the biopharmaceutical industry are accelerating market growth in the European region. Technological advancements by the key market players are increasing for the pharmaceutical industries' filters to boost market growth during the forecast period. Final product filtration is the quickest growing segment, and wide-spread research and development in the pharmaceutical industry are responsible for increasing briskly. The healthy presence of key players, the high demand for enhanced therapeutic drugs escalates the pharmaceutical membrane filtration market in Europe during the analysis period.
The high cost of the products and strict requirements for the pharmaceutical membrane filtration are majorly hindering the growth in the region.
This research report on the Europe Pharmaceutical Membrane Filtration Market has been segmented and sub-segmented into the following categories:
Regional Analysis:
The European pharmaceutical membrane filtration market is anticipated to hike a considerable growth rate during the forecast period, mainly due to the factors such as growing demand for filtration products in the filtration industry and the robust existence of crucial players region are projected to fuel the growth.
In the European market, the German pharmaceutical membrane filtration market is estimated to cover most of the market share in this region. Germany has advanced healthcare infrastructure, high investments made by the companies on R &D, robust growth in the biopharmaceutical industry, and increasing acquisition of membrane filters in sterile filtration, protein purification, and viral clearance process are mounting the market growth in this country.
France is considered as the biggest consumers of pharmaceutical products in the world. It is one of the problematic markets for the commodification of pharmaceutical products, and the enormous production of APIs is predicted to enhance market growth during the forecast period.
The UK market is expected to witness notable growth because of primarily developed healthcare infrastructure; colossal per capita income are the factors mounting the market in Europe. Italy market has got mushrooming international trade and fostering innovation. The pharmaceutical domain will continue to play a tactical role in which results in market growth.
Promising Companies dominating the Europe Pharmaceutical Membrane Filtration Market profiled in this report are Merck KGaA (Germany), General Healthcare Company (U.K.), Pall Corporation (U.S.), Sartorius Stedim Biotech Group (France), Alfa Laval (Sweden), Graver Technologies, LLC (U.S.), Koch Membrane Systems Inc. (U.S.), GEA Group (Germany), and Novasep (U.S.).
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 MCE Membrane Filters
5.1.2 Coated Cellulose Acetate Membrane Filters
5.1.3 Nylon Membrane Filters
5.1.4 PTFE Membrane Filters
5.1.5 PVDF Membrane Filters
5.1.6 Other Membrane Filters
5.1.7 Y-o-Y Growth Analysis, By Product
5.1.8 Market Attractiveness Analysis, By Product
5.1.9 Market Share Analysis, By Product
5.2 Technique
5.2.1 Microfiltration
5.2.2 Ultrafiltration
5.2.3 Nanofiltration
5.2.4 Crossfiltration
5.2.5 Reverse Osmosis
5.2.6 Ion Exchange
5.2.7 Y-o-Y Growth Analysis, By Technique
5.2.8 Market Attractiveness Analysis, By Technique
5.2.9 Market Share Analysis, By Technique
5.3 Application
5.3.1 Final Product Processing
5.3.2 Raw Material Filtration
5.3.3 Cell Separation
5.3.4 Water Purification
5.3.5 Air Purification
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Technique
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Technique
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Technique
6.1.5.4 By Application
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
6.7 Rest of Europe
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Novasep
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Merck KGaA (Germany)
8.3 GE Healthcare Company (U.K.)
8.4 Pall Corporation (U.S.)
8.5 Sartorius Stedim Biotech Group (France)
8.6 Alfa Laval (Sweden)
8.7 Graver Technologies
8.8 LLC (U.S.)
8.9 Koch Membrane Systems Inc. (U.S.)
8.10 GEA Group (Germany)
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
